Merkin Prize in Biomedical Technology awarded to F. William Studier for development of widely used protein- and RNA-production platform
Broad Institute
MAY 14, 2024
His T7 expression technology can be used to make large quantities of nearly any RNA or protein and has been for decades, and continues to be, a mainstay of biomedical research and pharmaceutical production. In 2020, scientists used the T7 platform to produce enough mRNA for COVID-19 vaccines to vaccinate millions of people in the U.S.
84 
Let's personalize your content